ENvue Medical, Inc.

ENvue Medical, Inc. is a U.S.-based medical device company focused on products used in surgical and procedural care. Based on the available filings, the company appears to be in a capital-intensive commercialization and financing phase, with operations shaped by public-company listing requirements and ongoing access to capital.

−861,4 %

6,0 %

−712,3 %

−0,2 %

1.09

0.74

— ENvue Medical, Inc.
%
Surgical and procedural devices60% Devices used in operative and procedural settings to support clinical workflows and patient care.
Orthopedic and prosthetic supplies25% Supplies and appliances used in orthopedic and prosthetic applications.
Clinical support and accessories15% Ancillary products and accessories that support use of the core device platform.

ENvue Medical sells into healthcare settings that need surgical and procedural products, with demand driven by...

  • Hospitals and health systemsprimary

    Buy surgical and procedural devices for inpatient and outpatient care and prioritize reliability, compliance, and clinical fit.

  • Ambulatory surgical centerssecondary

    Purchase procedure-focused products that support efficient outpatient workflows and cost control.

  • Orthopedic and prosthetic care providerssecondary

    Buy supplies and appliances used in orthopedic and prosthetic applications.

  • Distributors and channel partnersemerging

    Help place products into healthcare accounts and expand market access.

ENvue Medical is headquartered in the United States, and the available excerpts do not disclose a detailed...

  • •United States is the primary corporate and commercial base
  • •Israel-related subsidiary activity appears in employment disclosures
  • •No country-level revenue split was disclosed in the excerpts
  • •Public-market access is important to fund operations and commercialization

The filings suggest the company’s near-term priority is maintaining SEC reporting, Nasdaq compliance, and financing...

01
Restore and maintain audit and filing continuityshort-term

Timely SEC reporting is necessary for market credibility and capital access.

02
Protect Nasdaq listing complianceshort-term

Listing status affects liquidity, valuation, and the ability to raise capital.

03
Secure financing for operationsmedium-term

The company appears dependent on external funding to support ongoing business activities.

The most immediate risks disclosed in the filings are audit disruption and potential Nasdaq delisting, both of which...

high

Auditor dismissal and possible re-audit delays

The prior auditor could no longer serve, which may delay SEC filings and financings.

Scope
SEC reporting, capital raising, investor confidence
Materiality
high
high

Nasdaq delisting

The company must meet continued listing requirements including equity and bid price thresholds.

Scope
Liquidity, valuation, access to public capital markets
Materiality
high
medium

Financing covenant restrictions

The Series H Purchase Agreement includes restrictive covenants that may limit additional financing.

Scope
Balance sheet flexibility and operating runway
Materiality
high
medium

Medical device commercialization risk

Revenue depends on market acceptance, clinical adoption, and effective distribution.

Scope
Product uptake and customer retention
Materiality
medium
Audited financial statement continuity
Could affect SEC reporting timeliness and financing transactions
Debt and secured note accounting
May affect liability classification, interest expense, and covenant analysis
Equity issuance and financing costs
Affects share count, EPS, and cash runway interpretation

enVVeno Medical Corp

NVNO · Surgical & Medical Instruments & Apparatus

Envoy Medical, Inc.

COCH · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Enovis CORP

ENOV · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Enhabit, Inc.

Services-Home Health Care Services

Medicale Corp.

MCLE · Services-Health Services

InnovAge Holding Corp.

INNV · Services-Health Services

: 28.4.2026